Benoit Destenaves

Benoit Destenaves has extensive experience in the pharmaceutical industry, specializing in oncology and translational medicine. Most recently, Benoit served as Senior Director at AstraZeneca, overseeing Oncology Translational Medicine Operations and Experimental Oncology, as well as leading clinical multi-omics efforts. Prior to this role, Benoit was Executive Director at H3 Biomedicine, directing a team focused on clinical translational medicine, patient selection, and diagnostic development. Benoit's career at AstraZeneca included significant positions as Director of Precision Medicine and Director of Pharmacogenomics and Molecular Diagnostics Labs, where strategies for precision medicine and pharmacogenomics were defined and implemented. Earlier experience at Merck Serono included leadership roles in biomarkers and personalized medicine, with efforts concentrated on endocrinology and fertility. Benoit's foundation in the field began at Serono, where pharmacogenomics project management was established across various clinical trials. Benoit holds a PharmD from Paris-Sud University.